✦ LIBER ✦

How, why, and when does primary biliary cirrhosis recur after liver transplantation?

✍ Scribed by Roger Williams; M. Eric Gershwin

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 67 KB
Volume: 13
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21143

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppression affects the rate of re

Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation

✍ James Neuberger; Bridget Gunson; Stefan Hubscher; Peter Nightingale 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Recurrence of autoimmune disease, primar

Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation

✍ Jean-Charles Duclos-Vallee; Mylène Sebagh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

1. Recurrence of primary sclerosing cholangitis. a Five percent of liver transplants are performed because of end-stage liver disease secondary to primary sclerosing cholangitis. b Recurrent disease affects 10% to 27% of recipients. c Diagnostic criteria of recurrence include the following: A confir

Primary biliary cirrhosis after liver tr

Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity

✍ Pinelopi Manousou; Vasiliki Arvaniti; Emmanuel Tsochatzis; Graziella Isgro; Kate 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Patients with primary biliary cirrhosis (PBC), despite excellent outcomes after liver transplantation (LT), may develop recurrent primary biliary cirrhosis (rPBC). The impact of immunosuppression and HLA mismatches on rPBC is unclear. We evaluated 103 consecutive PBC patients who underwent transplan

Long-term survival and impact of ursodeo

Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were

Granulomatous destruction of bile ducts

Granulomatous destruction of bile ducts after liver transplantation: Primary biliary cirrhosis recurrence or hepatitis C virus infection?

✍ Olivier Farges; Henri Bismuth; Mylène Sebagh; Michel Reynes; Vijayan Balan; Mich 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 2 views

Does antimitochondrial antibody status a

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

✍ W R Kim; J J Poterucha; R A Jorgensen; K P Batts; H A Homburger; E R Dickson; R 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri